Migration of fresh human malignant astrocytoma cells into hydrated gel wafers in vitro
Individual astrocytoma cells expressing a cytoplasmic form of pl85 c-neu migrated along basement membrane lined surfaces after xenografing fresh low or high grade human malignant astrocytomas into host rat brain. We now study the migratory capacity of fresh human malignant astrocytoma cells seeded on hydrated gel wafers composed of artificial basement membrane or collagen I, a normal and lesion-related CNS extracellular matrix component. Approximately 107 mechanically disrupted cells (with small clumps) of 3 fresh low grade and 6 fresh high grade astrocytomas were seeded on the surface of artificial basement membrane and collagen I wafers (11 × 16 mm). The wafers were then prepared for scanning electron microscopy and immunohistochemstry at 1, 3, 5, and 7 days after seeding. Regardless of tumor grade, a morphologically similar class of cells was observed to migrate through collagen I gels in 24 hours and 0.5–1.5 mm into artificial basement membrane gels in 7 days. Immunohistochemistry revealed that the migrated cells from low and high grade astrocytomas were positive for glial fibrillary acidic protein (GFAP)) and expressed cytoplasmic human-specific pl85 c-neu . These data indicate that fresh human malignant astrocytoma cells that contain GFAP and express cytoplasmic pl85 c-neu have a high degree of migratory capacity and could be the cell in the tumor involved in intraparenchymal metastasis and poor patient survival in high grade astrocytomas of the human brain.
Key wordshuman astrocytoma receptor tyrosine kinase c-neu oncoprotein metastasis migration
Unable to display preview. Download preview PDF.
- 5.Bernstein JJ, Goldber W, de Vellis J (eds): Migration of glia, gliomas and neurons transplanted to the central nervous system. Int J Dev Neurosci 11:523–697, 1993Google Scholar
- 12.Burger P: Glioma: pathology. In: Wilkins R, Rengachary S (eds) Neurosurgery. McGraw-Hill Book Company, New York, 553–563, 1985Google Scholar
- 14.Burger PC, Vogel FS: Surgical pathology of the nervous system and its coverings, 2nd Ed., John Wiley & Sons, New York, 226–266, 1982Google Scholar
- 23.Kelly P, Daumas-Duport C, Kispert D, Kall B, Scheithauer B, Illig J: Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosci 66: 865–874, 1987Google Scholar
- 29.Marchionni MA, Goodearl ADJ, Chen MS, Bermingham-McDonogh O, Kirk C, Hendricks M, Danehy F, Misumi D, Sudhalter J, Kobayashi K, Wroblewski D, Lynch C, Baldassare M, Hiles I, Davis JB, Hsuan JJ, Totty NF, Otsu M, McBurney RN, Waterfield MD, Stroobant P, Gwynne D: Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system. Nature 362: 312–318, 1993PubMedCrossRefGoogle Scholar
- 32.Okazaki H, Scheithauer B: Atlas of neuropathology. Gower Medical Publishing, New York, 59–71, 1990Google Scholar
- 37.Scherer H: Structural development in gliomas. Am J Cancer 34: 333–351, 1938Google Scholar